MoneyWorks4Me

The revenue slipped marginally during the September 2024 quarter. A decline of about Rs. 403.23 millions was observed as compared to Rs. 406.78 millions during the corresponding quarter last year.The Company has registered profit of Rs. 26.16  millions for the quarter ended September 2024, a growth of 5.31%  over Rs. 24.84 millions millions achieved in the corresponding quarter of last year.Operating profit for the quarter ended September 2024 rose to 48.14 millions as compared to 41.63 millions of corresponding quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 403.23 406.78 -0.87 736.09 826.25 -10.91 1524.66 1153.50 32.18
Other Income 10.22 1.59 542.77 15.27 20.28 -24.70 35.22 32.73 7.61
PBIDT 48.14 41.63 15.64 65.31 123.26 -47.01 146.34 189.90 -22.94
Interest 6.23 4.38 42.24 12.74 10.39 22.62 22.90 20.38 12.37
PBDT 41.91 37.25 12.51 49.12 112.87 -56.48 123.44 169.52 -27.18
Depreciation 15.75 12.41 26.91 30.19 24.53 23.07 49.95 53.34 -6.36
PBT 26.16 24.84 5.31 18.93 88.34 -78.57 73.49 116.18 -36.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.78 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 26.16 24.84 5.31 18.93 88.34 -78.57 73.49 113.40 -35.19
Equity 236.56 236.56 0.00 236.56 236.56 0.00 236.56 236.56 0.00
PBIDTM(%) 11.94 10.23 16.66 8.87 14.92 -40.52 9.60 16.46 -41.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..